Concord Biotech Faces Declining Performance Amid Bearish Technical Outlook

Aug 29 2025 08:26 AM IST
share
Share Via
Concord Biotech has recently adjusted its evaluation score due to a shift in technical indicators. The company has faced a challenging performance landscape, with notable declines in stock returns and key financial metrics for Q1 FY25-26, alongside a decrease in institutional investor participation.
Concord Biotech, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in technical indicators, with the technical trend moving from a mildly bearish stance to a bearish outlook.

The stock's performance metrics reveal a challenging landscape. Over the past week, Concord Biotech has experienced a return of -5.2%, while the Sensex returned -2.34%. In the month leading up to this adjustment, the stock's return was -10.58%, contrasting with a modest -1.00% return for the Sensex. Year-to-date, the stock has seen a decline of 24.62%, while the Sensex has gained 2.48%.

Financially, the company reported a significant drop in key performance indicators for Q1 FY25-26, with net sales at Rs 203.99 crore, marking a low point. The operating profit has shown a growth rate of 19.91% over the past five years, but recent quarterly figures indicate a decline in profit before tax and profit after tax compared to previous averages.

Additionally, institutional investor participation has seen a slight decrease, with their collective stake now at 17.97%. This trend, coupled with a high price-to-book value ratio of 9.6, suggests a premium valuation relative to peers.

For more insights on Concord Biotech's financial trend performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News